Joslin Diabetes Center, headquartered in Boston, MA, is a national and international leader in diabetes treatment and research. Joslin is affiliated with Harvard Medical School. Joslin has locations throughout the Boston metropolitan area and offers affiliated programs throughout the U.S.
Joslin's tradition of excellence in diabetes is reflected in the high level of satisfaction patients express in the care and education they receive. Nearly 90 percent of new patients to the Center consistently rate their experience as "very positive." Recent studies show that most patients say their Joslin experience is better than previous treatment they have received for their diabetes.
One hundred years of experience
Joslin was established more than 100 years ago as the private practice of Elliott P. Joslin, MD. Dr. Joslin was a diabetes specialist for over 60 years, beginning in an era 25 years before the discovery of lifesaving insulin. Dr. Joslin and his colleagues were the first to use insulin in New England following its discovery.
Continuous innovation and discovery
In addition to being a leader in educating patients and urging blood sugar control, Dr. Joslin and those who have followed him have developed numerous innovative treatments and protocols to help people with diabetes. For example:
- Joslin clinicians developed treatment programs which enable women with diabetes to deliver healthy babies, increasing the fetal survival rate from about 50 percent to over 95 percent. This survival rate is nearly identical to that of non-diabetic women.
- Joslin researchers identified ways to determine who will develop type 1 (insulin-dependent) diabetes years in advance of symptoms. They also identified treatments that may prevent the disease, and these treatments are now being tested in a nationwide trial to prevent type 1 diabetes.
- Joslin eye specialists led efforts to develop laser treatment for diabetic eye disease, now making it possible to prevent most cases of vision loss due to diabetes.
- Joslin researchers and clinicians began writing publications for patients and professionals in 1916. These books, now in their 13th and 14th editions, have educated generations of clinicians and patients about how to treat diabetes.
Survey of over 400 new Joslin patients, when asked "Overall, how would you rate your experience with Joslin?"
|87% Very positive|
10% Somewhat positive
2% Neither positive or Negative
1% More negative than positive
Page last updated: October 05, 2015